Rezolute, Inc. (RZLT) Financials

RZLT Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 125.5 million 8.6 million
Dec. 31, 2025 138.6 million 10.6 million
Sept. 30, 2025 158.7 million 11.5 million
June 30, 2025 175.5 million 13.4 million

RZLT Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -13.7 million 4.4 million
Dec. 31, 2025 -20.3 million 3.4 million
Sept. 30, 2025 -17.4 million 2.5 million
June 30, 2025 -22.0 million 2.4 million

RZLT Net Income

No data available :(

RZLT Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 120.3 million - 438000
Dec. 31, 2025 132.9 million - 1.3 million
Sept. 30, 2025 152.2 million - 1.5 million
June 30, 2025 167.9 million - 1.6 million

RZLT Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 104.0 million
Dec. 31, 2025 103.7 million
Sept. 30, 2025 103.4 million
June 30, 2025 94.3 million

RZLT Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 11.4 million 5.9 million -
Dec. 31, 2025 - 14.3 million 9.9 million -
Sept. 30, 2025 - 13.1 million 6.8 million 167000
June 30, 2025 - 20.9 million 5.0 million -

RZLT Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 8000
Dec. 31, 2025 - 7000
Sept. 30, 2025 - 8000
June 30, 2025 46000 8000

RZLT

Price: $4.68

52 week price:
1.07
11.46

Earnings Per Share: -0.79 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 23600

Market Capitalization: 449.2 million

Links: